Atlantic Lithium Limited. ALL
LSE · United Kingdom · Non-Energy Minerals
GBp 14.65-0.35 (-2.33%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
CelLBxHealth PLC (AIM:CLBX, FRA:DWV) is in advanced talks with one of the largest private US healthcare providers to deploy its Parsortix cancer diagnostic platform. In a first quarter trading update, the company guided for revenues of at least £2.1 million this year, a 50% increase, with further upgrades possible if pipeline deals convert. Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) has secured a Canadian patent for its POLB 001 drug candidate in preventing cancer immunotherapy-induced cytokine release syndrome. CEO Jeremy Skillington says the grant strengthens the drug's appeal to pa
Elevra Lithium (ELVR) agreed to sell its interest in Ghana's Ewoyaa lithium project to Zhejiang Huay
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) told investors that it has consented to Elevra Lithium transferring its rights and obligations in the Ewoyaa Lithium Project to Zhejiang Huayou Cobalt, potentially simplifying the funding route for Ghana’s flagship lithium...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.